Apimeds Pharmaceuticals US Inc (APUS)

Ticker: APUS Exchange: ASE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Apimeds Pharmaceuticals US Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Kim Christopher Chairman and CMO Executive Director
Transaction date
Purchase
Price
224.18
Quantity 90,388 +44.1%
Value US$4,914,605
2.2
Kim Christopher Chairman and CMO Executive Director
Transaction date
Purchase
Price
219.15
Quantity 88,194 -20.8%
Value US$3,104,080
1.3
Koo Jakap Non-Executive Director
Transaction date
Purchase
Price
306.81
Quantity 44,972 +49.9%
Value US$1,821,767
Inscobee Inc. Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 500,000 +33.7%
Value US$2,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-15 2025-05-14 B Purchase

Chairman and CMO

Executive Director
90,388 +44.1%
224.18
US$4,914,605
90,388 +44.1% 224.18 US$4,914,605
2025-05-15 2025-05-13 B Purchase

Chairman and CMO

Executive Director
88,194 -20.8%
219.15
US$3,104,080
88,194 -20.8% 219.15 US$3,104,080
2025-05-14 2025-05-12 B Purchase Non-Executive Director
44,972 +49.9%
306.81
US$1,821,767
44,972 +49.9% 306.81 US$1,821,767
2025-05-14 2025-05-12 B Purchase Large shareholder
500,000 +33.7%
4.00
US$2,000,000
500,000 +33.7% 4.00 US$2,000,000